Skip to content

BALL KRISTINE M

Reporting owner on Forms 3, 4 and 5, CIK 1266163.

BALL KRISTINE M reported on 2 issuers in 3 filings, the latest a Form 4 filed 2026-11-13.

Issuers

IssuerRoles in the latest filingFilingsLast filed
ORKA · Oruka Therapeutics, Inc.CIK 907654director12026-11-13
Enliven Therapeutics, Inc. CIK 1672619director12026-10-16

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12M exercised+18,000$6.8418,000Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12S sold-1,196$102.096716,804Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12S sold-1,300$103.093215,504Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12S sold-2,039$104.162213,465Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12S sold-10,765$105.31412,700Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12S sold-2,500$106.052200Form 4
ORKA · Oruka Therapeutics, Inc.Common Stock2026-11-12S sold-200$106.9850Form 4
ORKA · Oruka Therapeutics, Inc.Stock Option (Right to Buy), derivative2026-11-12M exercised-18,000$053,426Form 4
ELVN · Enliven Therapeutics, Inc.Stock Option (right to buy), derivative2026-10-14A granted+23,394$023,394Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0000907654-26-000115 Oruka Therapeutics, Inc.2026-11-13
Form 4 0001266163-26-000003 Enliven Therapeutics, Inc.2026-10-16
Form 3 0001266163-26-000002 Enliven Therapeutics, Inc.2026-10-16